The phase 3 trial results for lecanemab and gantenerumab presented at the Clinical Trials on Alzheimer's Disease (CTAD) conference demonstrate why optimal treatment of...
Esperovax, a leading developer of oral vaccines, announced it has signed a new, exclusive licensing agreement with Innovation Partners at the University of Michigan...
The U.S. Food and Drug Administration approved Rebyota, the first fecal microbiota product approved by the agency. Rebyota is approved for the prevention of...
With AI becoming an integral part of clinical radiology workflows, the data used to develop AI algorithms is ever essential. An identified industry challenge...
Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, announced the market launch of the moresolution Power...
